Wolverine Trading, LLC Bio N Tech Se Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$78.36 - $124.66 $1.01 Million - $1.61 Million	12,900 Added 47.43%	40,100 $4.76 Million
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $265,188 - $339,471	3,300 Added 13.81%	27,200 $2.19 Million
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $765,056 - $966,210	-8,600 Reduced 26.46%	23,900 $2.2 Million
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $1.44 Million - $1.78 Million	15,800 Added 94.61%	32,500 $3.43 Million
Q3 2023 Nov 15, 2023	SELL	$98.5 - $125.08 $699,350 - $888,068	-7,100 Reduced 29.83%	16,700 $1.81 Million
Q2 2023 Aug 23, 2023	BUY	$102.58 - $129.66 $2.44 Million - $3.09 Million	23,800 New	23,800 $2.57 Million
Q4 2022 Feb 14, 2023	SELL	$118.43 - $186.05 $1.01 Million - $1.58 Million	-8,500 Reduced 17.78%	39,300 $5.9 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $791,430 - $1.14 Million	-6,200 Reduced 11.48%	47,800 $6.39 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $3.52 Million - $5.33 Million	-28,600 Reduced 34.62%	54,000 $7.67 Million
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $10.9 Million - $20.1 Million	-86,500 Reduced 51.15%	82,600 $14.4 Million
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $2.9 Million - $4.86 Million	-13,400 Reduced 7.34%	169,100 $43.4 Million
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $14.3 Million - $31.1 Million	69,500 Added 61.5%	182,500 $50.6 Million
Q2 2021 Aug 06, 2021	BUY	$113.32 - $241.49 $5.99 Million - $12.8 Million	52,900 Added 88.02%	113,000 $25.8 Million
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $1.85 Million - $2.58 Million	21,600 Added 56.1%	60,100 $6.28 Million
Q4 2020 Feb 12, 2021	BUY	$72.71 - $129.54 $2.8 Million - $4.99 Million	38,500 New	38,500 $3.23 Million

Others Institutions Holding BNTX

# of Institutions

356

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $26.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account